OTO-413

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameOTO-413
Drug Alias NameOTO-413
ClassificationBiologics
Mechanisms of ActionNerve growth factor receptors agonists
TargetsNerve growth factor receptors
Therapy Area/IndicationsHearing Loss, Sensorineural
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOtonomy Inc
China Registration ClassN/A

Develop Information

Active CompaniesSpiral TherapeuticsOtonomy Inc
Inactive CompaniesN/A
Active IndicationsHearing Loss, Sensorineural
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A